Investing Profile

Houman Ashrafian

InvestorVC
Managing Partner at SV Health Investors
Photo of Houman Ashrafian, Managing Partner at SV Health Investors

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
University of Oxford Network
266 CONNECTIONS
University of Oxford Network
266 CONNECTIONS
University of Cambridge Network
258 CONNECTIONS
cb
SV Health Investors Managing Partner
$100K - $5.0M
$1.5M
8
£200M
CompanyStageDateRound SizeTotal Raised
Therini Bio
Series AMay 2025$39M
Series AApr 2023$36M
$100M
Co-investors: Laurence Barker (SV Health Investors' Dementia Discovery Fund (DDF)), Mike Ross (SV Health Investors), Pascal Levensohn (Dolby Family Ventures), Jim Trenkle (Sanofi Ventures)
Quell Therapeutics
Series BNov 2021$160M
$160M
Mestag Therapeutics
SeedApr 2021$11M
$51M
Co-investors: David Schenkein (GV (Google Ventures)), Issi Rozen (GV (Google Ventures))
Alchemab Therapeutics
Series AApr 2021$83M
$120M
Co-investors: Andrew Levin (RA Capital Management), Kate Bingham (SV Health Investors)
Catamaran Bio
Series ANov 2020$42M
$47M
Co-investors: Jack Kenney (SV Health Investors), Caroline Gaynor (Lightstone Ventures), Maina Bhaman (Sofinnova Partners)
Enara Bio
Series ANov 2019$18M
$51M
Co-investors: Rana Al-Hallaq (Pfizer Venture Investments)
Sitryx Therapeutics
Series AOct 2018$30M
$30M
Co-investors: Maina Bhaman (Sofinnova Partners)
Director HotmailPresent
Honorary Consultant Cardiologist / Co-lead inherited cardiac conditions service Oxford University Hospitals NHS Foundation TrustPresent
Head of Experimental Therapeutics - Radcliffe Department of Medicine University of OxfordPresent
Vice President of Experimental Therapeutics UCBPresent
Director SitryxPresent
Chairman Of The Board Enara BioPresent
Chairman Of The Board WeatherdenPresent
Chairman Of The Board TRexBioPresent
Director Karus Therapeutics LimitedPresent
Investment Advisor SV Health Investors' Dementia Discovery Fund (DDF)Present
Chairman Of The Board Alchemab Therapeutics LtdPresent
Director CellintaPresent
Chairman Of The Board Mestag TherapeuticsPresent
Director Catamaran BioPresent
Executive Vice President, Head of Research and Development SanofiPresent
Founder and Director HotmailPresent
Venture Partner SV Health InvestorsPresent
Partner SV Health InvestorsPresent
Managing Partner SV Health InvestorsPresent
University of Cambridge BA (Hons) Medicine
University of Oxford BM BCh Medicine
University of Oxford Doctor of Philosophy (Ph.D.) Cardiovascular|Medicine